Reproxalap Improves Ocular Redness, Tear Production, and Symptoms in a Pivotal Dry Eye Disease Chamber Trial

Authors:

Abstract
No abstract available
Funding Information
  • Aldeyra Therapeutics Inc

This publication has 29 references indexed in Scilit: